Open access
Open access
Powered by Google Translator Translator

General Interest

China has promised millions of coronavirus vaccines to countries globally. And it is ready to deliver them.

4 Dec, 2020 | 08:12h | UTC

China has promised millions of coronavirus vaccines to countries globally. And it is ready to deliver them – CNN

 


WHO looks at possible ‘e-vaccination certificates’ for travel

4 Dec, 2020 | 08:09h | UTC

WHO looks at possible ‘e-vaccination certificates’ for travel – Reuters

 


UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week

3 Dec, 2020 | 08:44h | UTC

UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week – CNN

Press release: UK medicines regulator gives approval for first UK COVID-19 vaccine – Medicines and Healthcare products Regulatory Agency

See also: Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK – BBC AND Expert reaction to news that the MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for mass UK roll out – Science Media Centre AND UK approves Pfizer/BioNTech Covid vaccine for rollout next week – The Guardian

 


WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19

3 Dec, 2020 | 08:47h | UTC

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results – New England Journal of Medicine

Audio Interview: Caring for Hospitalized Patients with Covid-19

 

Commentary on Twitter (thread – click for more)

 


CDC to shorten COVID-19 quarantine to 10 days, 7 with test

3 Dec, 2020 | 08:40h | UTC

CDC to shorten COVID-19 quarantine to 10 days, 7 with test – Associated Press

Commentary: CDC Shortens Its COVID-19 Quarantine Recommendations – NPR

 


Special Report: The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

3 Dec, 2020 | 08:42h | UTC

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them – STAT

 


Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

2 Dec, 2020 | 07:31h | UTC

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer – New England Journal of Medicine

 


What’s the difference between viral shedding and reinfection with COVID-19?

2 Dec, 2020 | 07:29h | UTC

What’s the difference between viral shedding and reinfection with COVID-19? – The Conversation

 


Opinion: “Put an end to publication by proclamation for Covid vaccines”

2 Dec, 2020 | 07:27h | UTC

Put An End To Publication By Proclamation For Covid Vaccines – Forbes

 


CDC panel moves health workers, nursing home residents to front of COVID vaccine line

2 Dec, 2020 | 07:26h | UTC

CDC panel moves health workers, nursing home residents to front of COVID vaccine line – CIDRAP

See also: Health workers, long-term care facilities should get Covid-19 vaccine first, CDC advisory panel says – STAT

 


Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”

2 Dec, 2020 | 07:19h | UTC

Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review – The Journal of Infectious Diseases

 

Commentary on Twitter

 


Moderna released more Covid-19 vaccine results. They’re very encouraging.

1 Dec, 2020 | 08:15h | UTC

Moderna released more Covid-19 vaccine results. They’re very encouraging. – Vox

News release: Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP

 

Commentary on Twitter

 


Opinion: How Prestige Journals Remain Elite, Exclusive and Exclusionary. “by announcing a €9,500 price tag, Nature has failed to enact their own diversity and inclusion pledge”

1 Dec, 2020 | 08:22h | UTC

How Prestige Journals Remain Elite, Exclusive And Exclusionary – Forbes

See also: For €9500, Nature journals will now make your paper free to read

 


Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

1 Dec, 2020 | 08:13h | UTC

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data – BMJ Opinion

 


The Ioannidis affair: A tale of major scientific overreaction

1 Dec, 2020 | 08:10h | UTC

The Ioannidis Affair: A Tale of Major Scientific Overreaction – Scientific American

 


The COVID science wars: Shutting down scientific debate is hurting the public health

1 Dec, 2020 | 08:11h | UTC

The COVID Science Wars – Scientific American

 


Report: SARS-CoV-2 setting-specific transmission rates. Households showed the highest transmission rates (21.1%). Asymptomatic infections do occur but much less efficiently than symptomatic infection.

30 Nov, 2020 | 01:01h | UTC

Report 38 – SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis – Imperial College London

Full report: SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis – Imperial College London

Commentary: Expert reaction to systematic review and meta-analysis on setting-specific transmission rates of SARS-CoV-2 – Science Media Centre

 


AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose

1 Dec, 2020 | 08:05h | UTC

AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose – Health Policy Watch

 


No evidence for increased transmissibility from mutations in SARS-CoV-2

30 Nov, 2020 | 01:06h | UTC

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 – Nature Communications

Commentaries: Mutations not making coronavirus able to spread more rapidly -study – Reuters AND Covid-19 has NOT become more infectious: Study identifies almost 13,000 coronavirus mutations but none – including the dominant D614G strain – made it better at spreading – Daily Mail

 


For €9500, Nature journals will now make your paper free to read

30 Nov, 2020 | 00:49h | UTC

For €9500, Nature journals will now make your paper free to read – Science

News release: Nature journals reveal terms of landmark open-access option

 


New WHO guidelines on physical activity and sedentary behavior – Every move counts towards better health

27 Nov, 2020 | 08:45h | UTC

WHO guidelines on physical activity and sedentary behaviour – World Health Organization

See also: World Health Organization 2020 guidelines on physical activity and sedentary behaviour – British Journal of Sports Medicine

News release: Every move counts towards better health – says WHO

Commentaries: Aim to exceed weekly recommended physical activity level to offset health harms of prolonged sitting – BMJ AND You only need 30 to 40 minutes of exercise per day to ‘offset’ sitting at your desk all day, new analysis finds – Business Insider AND Physical activity guidelines 2020: comprehensive and inclusive recommendations to activate populations – The Lancet

 

Commentary on Twitter

 


Long Covid: Comprehensive health assessment three months after recovery from acute COVID-19 revealed problems in several health domains in a substantial number of patients

27 Nov, 2020 | 08:33h | UTC

Comprehensive health assessment three months after recovery from acute COVID-19 – Clinical Infectious Diseases

 


Covid-19: 15% of people responsible for 80% of secondary infections

27 Nov, 2020 | 08:27h | UTC

Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 – Science

Commentary: What we can learn from contact tracing an entire province – Ars Technica

 

Commentary on Twitter

 


Perspective: “With global push for COVID-19 vaccines, China aims to win friends and cut deals”

27 Nov, 2020 | 08:26h | UTC

With global push for COVID-19 vaccines, China aims to win friends and cut deals – Science

 


CDC may shorten how long you quarantine if you are exposed to Covid-19 coronavirus

26 Nov, 2020 | 09:06h | UTC

CDC May Shorten How Long You Quarantine If You Are Exposed To Covid-19 Coronavirus – Forbes

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.